| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/07/1997 | US5674873 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof |
| 10/07/1997 | US5674854 Mixing diclofenac or salt and beta-cyclodextrin forming inclusion complex in the form of slurry or paste by continuous mixing of the water, drying the product |
| 10/07/1997 | US5674838 Cleavaged hirudin at amino acid position 36-37 or 63-64, linkaged with a polyether, amino compound or mono- or polysaccharides; anticoagulants |
| 10/07/1997 | US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin |
| 10/07/1997 | US5674534 Composition for sustained release of non-aggregated erythropoietin |
| 10/07/1997 | US5674533 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |
| 10/07/1997 | US5674531 Nanoparticles containing an active substance and a ketalized polytartramidic acid, process for their preparation, and use thereof |
| 10/07/1997 | US5674472 Drug delivery |
| 10/02/1997 | WO1997035604A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 10/02/1997 | WO1997035603A1 Cyclosporin a formulations as nanoparticles |
| 10/02/1997 | WO1997035597A1 Acne treatment |
| 10/02/1997 | WO1997035593A1 Polyethylene glycol esters of polyunsaturated fatty acids |
| 10/02/1997 | WO1997035587A1 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 10/02/1997 | WO1997035568A2 Diclofenac/gamma-cyclodextrin inclusion compounds |
| 10/02/1997 | WO1997035562A1 Polysaccharide microspheres for the pulmonary delivery of drugs |
| 10/02/1997 | WO1997035561A1 Materials and methods for making improved liposome compositions |
| 10/02/1997 | WO1997035560A1 Materials and methods for making improved echogenic liposome compositions |
| 10/02/1997 | WO1997024111A3 Novel hyaluronic acid receptors binding agents and the use thereof |
| 10/02/1997 | WO1997019675A3 Complex cationic lipids |
| 10/02/1997 | WO1997013502A3 Prolonged release of gm-csf |
| 10/02/1997 | DE19649606C1 System for identifying substances effective against HPV-associated carcinoma |
| 10/02/1997 | DE19612768A1 Cyclodextringruppen enthaltende Polymere, Verfahren zu ihrer Herstellung und ihre Verwendung Cyclodextringruppen containing polymers, to processes for their preparation and their use |
| 10/02/1997 | DE19612658A1 Verfahren zur Stabilisierung und Dispergierung von Pflanzenölen, die mehrfach ungesättigte Fettsäurereste enthalten, mittels gamma-Cyclodextrin sowie derart hergestellte Komplexe und ihre Verwendung A process for the stabilization and dispersion of vegetable oils containing polyunsaturated fatty acid residues, by means of gamma-cyclodextrin as well as complexes thus produced and their use |
| 10/02/1997 | CA2250383A1 Acne treatment |
| 10/02/1997 | CA2250053A1 Polysaccharide microspheres for the pulmonary delivery of drugs |
| 10/02/1997 | CA2250009A1 Diclofenac/gamma-cyclodextrin inclusion compounds |
| 10/02/1997 | CA2249578A1 Polyethylene glycol esters of polyunsaturated fatty acids |
| 10/02/1997 | CA2201457A1 Topical composition |
| 10/01/1997 | EP0797996A1 A pharmaceutical or veterinary composition which contains at least one volatile oil, at least one alcohol and at least one fixed oil |
| 10/01/1997 | EP0797991A1 Extended release formulation containing venlafaxine |
| 10/01/1997 | EP0797988A2 Anti-angiogenic compositions and methods of use |
| 10/01/1997 | EP0797983A2 Use of methyl ethers in cosmetic and/or pharmaceutical preparations |
| 10/01/1997 | EP0797965A1 Wound dressing and catheter securing using a polyurethane-biopolymer composite |
| 10/01/1997 | EP0797917A1 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 10/01/1997 | EP0797589A1 Peptides usable as vectors for the intracellular addressing of active molecules |
| 10/01/1997 | EP0797584A1 Cooperative combinations of ligands contained within a matrix |
| 10/01/1997 | EP0797456A1 Anticancer drug with a cytostatic and a contrasting agent |
| 10/01/1997 | EP0797452A1 Modulating the immune response |
| 10/01/1997 | EP0797443A1 A pharmaceutical composition with improved bio-availability of inositol phosphate |
| 10/01/1997 | EP0797441A1 Pharmaceutical composition comprising lamotrigine |
| 10/01/1997 | EP0797435A1 Controlled release matrix for pharmaceuticals |
| 10/01/1997 | EP0797433A1 Gas filled microspheres as magnetic resonance imaging contrast agents |
| 10/01/1997 | EP0797432A1 Oil-in-water emulsions |
| 10/01/1997 | EP0797431A1 Aerosol formulations of peptides and proteins |
| 10/01/1997 | EP0797430A1 Foamable formulation and foam |
| 10/01/1997 | EP0712330B1 Concentrated aqueous compositions of alkylpolyglycosides, and applications thereof |
| 10/01/1997 | CN1160999A Non-irritation, non-sensitizing non-ototoxic otic antibacterial compositions |
| 10/01/1997 | CN1160584A Sustained release formulation of animal growth hormone and process for preparation thereof |
| 09/30/1997 | US5672768 Low-odor, higher molecular weight polyether polyols, a process for producing them, and their use for the production of polymers, cosmetics and pharmaceutical products synthesized from polyether polyols |
| 09/30/1997 | US5672688 Immunoglobulin Fc fragment bound to an alkylating, antibiotic, or antimetabolic antitum or substance |
| 09/30/1997 | US5672687 Medical diagnosis; bone marrow transplants |
| 09/30/1997 | US5672683 Nerve growth factor or ciliary neurotrophic factor bound at its amino end to the carboxyl end of a transferrin, for delivery across blood brain barrier |
| 09/30/1997 | US5672659 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 09/30/1997 | US5672490 Method of cleaving DNA |
| 09/30/1997 | US5672486 Protein polyligands joined to a stable protein core |
| 09/30/1997 | US5672360 24-hour sustained release dosage of morphine or morphine sulfate |
| 09/30/1997 | US5672358 Controlled release aqueous emulsion |
| 09/30/1997 | US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles |
| 09/30/1997 | US5672336 Process of preparing microparticulate collagen, collagen-based products thereby and method of applying same |
| 09/30/1997 | CA2173037A1 Targeting of dosages of medicines and therapeutic agents and other glycosaminoglycans (gags) |
| 09/25/1997 | WO1997035200A1 Super-paramagnetic particles with increased r1 relaxivity, processes for producing said particles and use thereof |
| 09/25/1997 | WO1997034932A2 Compositions containing starch excipients |
| 09/25/1997 | WO1997034634A1 Single chain fv constructs of anti-ganglioside gd2 antibodies |
| 09/25/1997 | WO1997034631A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | WO1997034622A1 Oral cyclosporin formulations |
| 09/25/1997 | WO1997034615A1 Enhancement of microbial colonisation of the gastrointestinal tract |
| 09/25/1997 | WO1997034608A1 Combinations of an ursodeoxycholic acid compound and a nsaid for the chemopreventive protection of the colorectum |
| 09/25/1997 | WO1997034607A1 Topical formulations of aciclovir |
| 09/25/1997 | WO1997030024A3 Lipids and their use, for example, in liposomes |
| 09/25/1997 | WO1997029778A3 Bioresponsive pharmacologically-active polymers and articles made therefrom |
| 09/25/1997 | WO1997026867A3 Solid instant-release forms of administration and process for producing the same |
| 09/25/1997 | WO1997022363A3 Improved pharmaceutical compositions |
| 09/25/1997 | WO1997020579A3 Novel compounds and use |
| 09/25/1997 | WO1997020031A3 Rna polymerase ii carboxyl terminal domain-derived peptides |
| 09/25/1997 | DE19612001A1 Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung Superparamagnetic particles with increased relaxivity R¶1¶, methods of preparation and use thereof |
| 09/25/1997 | CA2249195A1 Immunoglobin-like domains with increased half lives |
| 09/24/1997 | EP0796624A2 Clathrates and edible compositions comprising the same |
| 09/24/1997 | EP0796623A2 Pharmaceutical preparation for the treatment of blood coagulation disorders |
| 09/24/1997 | EP0796403A1 Functionalized nanotubes |
| 09/24/1997 | EP0796326A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 09/24/1997 | EP0796324A1 Polypeptide with reduced allergenicity |
| 09/24/1997 | EP0796302A1 Anti-oxidant compositions |
| 09/24/1997 | EP0796240A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 09/24/1997 | EP0796238A1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
| 09/24/1997 | EP0796113A2 Stable n-terminally linked dtpa:protein compositions and methods |
| 09/24/1997 | EP0796112A1 Phosphocholine drug derivatives |
| 09/24/1997 | EP0796108A2 Water soluble ubiquinone compositions, prodrugs, and methods relating thereto |
| 09/24/1997 | EP0796106A1 Protracted glp-1 compositions |
| 09/24/1997 | EP0796090A2 Cross-linked microparticles and their use as therapeutic vehicles |
| 09/24/1997 | EP0796086A1 Sequestration agents |
| 09/24/1997 | EP0796085A1 Solubilisation aids for hydrophilic macromolecules |
| 09/24/1997 | EP0796080A1 Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss |
| 09/24/1997 | EP0673245B1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same |
| 09/24/1997 | EP0480925B1 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 09/24/1997 | CN1160356A Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 09/24/1997 | CN1160355A Stable, aqueous alpha interferon solution formulations |
| 09/24/1997 | CN1160354A Aromatic composition and use in medicines, cosmetics, perfume or sanitary health articles espercially |
| 09/24/1997 | CN1160349A Codeine contg. formulations |
| 09/24/1997 | CN1160348A Sabeluzole oral suspensions |
| 09/24/1997 | CN1160345A Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |